cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Perkinelmer Inc
8 own
5 watching
Current Price
$141.75
$-2.63
(-1.82%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
17,891.69M
52-Week High
52-Week High
190.56
52-Week Low
52-Week Low
113.46
Average Volume
Average Volume
0.76M
Dividend Yield
Dividend Yield
0.001658
P/E Ratio
P/E Ratio
16.0539
iconMarket Capitalization17,891.69M
icon52-Week High190.56
icon52-Week Low113.46
iconAverage Volume0.76M
iconDividend Yield0.001658
iconP/E Ratio16.0539
What does the Perkinelmer Inc do?
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, food, and laboratory services markets worldwide. The company operates through two segments, Discovery and Analytical Solutions and Diagnostics. The Discovery and Analytical Solutions segment develops and provides analytical technologies, solutions, and services that enable its customers to understand the characterization and health of various aspects, including air, water, and soil. It also provides solutions to farmers and food producers; an analytical instrumentation for the industrial market, which includes the chemical, electronics, energy, food, lubricant, petrochemical, and polymer industries; and laboratory services. This segment's offers a suite of solutions, including reagents, liquid handling systems, and detection and imaging technologies that enable scientists to enhance life sciences research and drug discovery processes. Its research portfolio includes a range of systems consisting of imaging, detection, and extraction instrumentation for use on in vitro, ex vivo, and in vivo models, analysis hardware, and software; and a range of consumable products, including drug discovery and research reagents. The Diagnostics segment provides early detection for genetic disorders from pregnancy to early childhood, as well as flat panel X-ray detectors and infectious disease testing for the diagnostics market. This segment also develops technologies that enable and support sample-to-sequencer workflow using next-generation DNA sequencing for applications in oncology, genetic testing, and drug discovery. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1931 and is headquartered in Waltham, Massachusetts.
Read More
How much money does Perkinelmer Inc make?
News & Events about Perkinelmer Inc.
Accesswire
19days ago
Mr. Rongen appointed as CEO and member of the Board bringing 30 years of executive leadership experience and expertise across a number of therapeutic areasBolstered expertise on Board of Directors with addition of Dr. Rogers who brings significant leadership and expertise spanning both public and...
Business Wire
1month ago
PerkinElmer Inc., (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 at 8:15 a.m. PT. Prahlad Singh, president and chief executive officer, will...
Zolmax
1month ago
PerkinElmer, Inc. (NYSE:PKI Get Rating) has earned a consensus rating of Hold from the thirteen research firms that are currently covering the stock, MarketBeat.com reports. Six investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the ...
Business Wire
2 months ago
PerkinElmer Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 2022 Stifel Healthcare Conference on Wednesday, November 16, 2022 at 9:10 a.m. ET in New York, NY. Max Krakowiak, senior vice president and chief...
Business Wire
3 months ago
PerkinElmer Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today released its 2022 Environmental, Social and Governance (ESG) Report. The report describes progress on the Companys previously stated goals, builds on the Companys ESG commitments and summarizes its...
Frequently Asked Questions
Frequently Asked Questions
What is Perkinelmer Inc share price today?
plus_minus_icon
Can Indians buy Perkinelmer Inc shares?
plus_minus_icon
How can I buy Perkinelmer Inc shares from India?
plus_minus_icon
Can Fractional shares of Perkinelmer Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Perkinelmer Inc stocks?
plus_minus_icon
What is today’s traded volume of Perkinelmer Inc?
plus_minus_icon
What is today’s market capitalisation of Perkinelmer Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Perkinelmer Inc?
plus_minus_icon
What percentage is Perkinelmer Inc down from its 52-Week High?
plus_minus_icon
What percentage is Perkinelmer Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$141.75
$-2.63
(-1.82%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Globus Medical, Inc.
Globus Medical, Inc.
$79.63
$1.04 (1.32 %)
DENTSPLY International Inc.
DENTSPLY International Inc.
$38.44
$-1.22 (-3.08 %)
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
$272.88
$-9.00 (-3.19 %)
Teleflex Incorporated
Teleflex Incorporated
$258.47
$-3.75 (-1.43 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Globus Medical, Inc.
Globus Medical, Inc.
$79.63
$1.04 (1.32 %)
DENTSPLY International Inc.
DENTSPLY International Inc.
$38.44
$-1.22 (-3.08 %)
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
$272.88
$-9.00 (-3.19 %)
Teleflex Incorporated
Teleflex Incorporated
$258.47
$-3.75 (-1.43 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00